White Paper
Cahaba Medical Care
Cahaba Medical Care addressed health equity within their high-risk underserved patient population using autonomous AI to diagnose diabetic retinopathy in primary care during the COVID pandemic. Through implementation of LumineticsCore™ (formerly IDx-DR) at the point-of-care, Cahaba Medical Care was able to diagnose referable levels of diabetic retinopathy, catching disease that may have gone untreated otherwise.
Read this white paper to find out more about Cahaba Medical Care and how they’re addressing health equity with a high-risk underserved patient population using autonomous AI.
-
1 in 3 patients with diabetes had referable levels of diabetic retinopathy
-
30 people were found to have vision-threatening disease that may have gone undetected without the LumineticsCore point-of-care system
-
Within the first 90 days, over 100 exams were conducted and 28.6% were found to have positive signs of disease
View the Cahaba Medical Care White Paper
Notice: The content embedded within PDF files on this website ("Content") is provided solely for educational purposes. Digital Diagnostics ("Owner") holds exclusive rights to the Content, including but not limited to copyrights, trademarks, and any other intellectual property rights.